Medtronic Plc Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Medtronic Plc on March 14, 2019, covering events occurring on March 8, 2019. The filing addresses corporate governance changes regarding the Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel appointments and does not contain financial performance data.
Material Changes
- Board Expansion: The Board of Directors increased its size from 10 to 11 members.
- New Appointment: Andrea Goldsmith, Ph.D., was appointed as a new director effective March 11, 2019.
- Term Details: Dr. Goldsmith will serve until the 2019 Annual Meeting of Shareholders, where she is a nominee for election.
- Committee Assignments: Committee assignments for Dr. Goldsmith have not yet been determined.
Guidance, Outlook, and Compensation
There is no financial guidance, outlook, or management commentary on business risks in this filing. Regarding compensation, Dr. Goldsmith is eligible to receive an annual cash retainer and a director equity grant in accordance with the Company's non-employee director compensation policy detailed in the 2018 Definitive Proxy Statement. No reportable transactions between Dr. Goldsmith and the Company were disclosed.
Key Facts for Investor Verification
- Verify the effective date of Dr. Goldsmith's appointment (March 11, 2019).
- Confirm the total Board size is now 11 members.
- Review the attached press release (Exhibit 99.1) for additional biographical details on the new director.
- Note that committee assignments remain undetermined at the time of filing.